Chard Daniel R sold 9,545 shares of MEDIFAST INC at $11.98 for −$114k on Sep 28, 2026

Sell
Form 4 code S. Open-market or private sale of a non-derivative or derivative security.
Director
DIR
Filed Sep 30, 2026

Facts from the filing

Form 4 · Non-derivative, table I
Disclosed value
−$114,337.65Shares × reported price
Shares traded
9,545Common Stock
Price per share
$11.98Reported price. Read footnotes for ranges.
% of reported position traded
6.38%This security and ownership context
Holdings after
140,153.352Indirect · The Dan and Allyson Family Irrevocable Trust
Trade date
Sep 28, 2026Sell
Filed
Sep 30, 2026, 8:04 PM ET3-day reporting delay
Accession
0001628280-26-064063Code S · Transaction 232258
How reported position traded is calculated

Shares sold ÷ (holdings after + shares sold). Estimated position before: 149,698.352 shares.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Other trades in this filing

Trade dateActivitySharesPriceValueDetails
Sep 29, 2026Sell9,544$11.73−$111,951.12Trade 232259
2 transaction rows in this filing. Joint filers share the same rows.

MED price since this filing

Daily closing prices, with the filing date and available return windows. Return methodology
MED · Daily closing priceDaily price data is pending. The chart appears when valid daily closes are available.
Filing dateReturn windows appear as prices become available.
Pre-filing1mo ago +6.6%1w ago +7.3%1d ago +6.5%
Returns since7d 0%30d +6.3%90d180d1y

Footnotes in full

F1: The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $11.900 to $12.125, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F2: These shares are directly owned by The Dan and Allyson Family Irrevocable Trust, for which the reporting person is the Settlor of the Trust and Investment Trustee. F3: The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $11.670 to $11.810, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F4: These shares are directly owned by a joint account of which the reporting person owns as a joint tenant with his spouse.